388 related articles for article (PubMed ID: 33537085)
41. FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis.
Al-Tamari HM; Dabral S; Schmall A; Sarvari P; Ruppert C; Paik J; DePinho RA; Grimminger F; Eickelberg O; Guenther A; Seeger W; Savai R; Pullamsetti SS
EMBO Mol Med; 2018 Feb; 10(2):276-293. PubMed ID: 29217661
[TBL] [Abstract][Full Text] [Related]
42. Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis.
MacKenzie B; Korfei M; Henneke I; Sibinska Z; Tian X; Hezel S; Dilai S; Wasnick R; Schneider B; Wilhelm J; El Agha E; Klepetko W; Seeger W; Schermuly R; Günther A; Bellusci S
Respir Res; 2015 Jul; 16(1):83. PubMed ID: 26138239
[TBL] [Abstract][Full Text] [Related]
43. Inhaled siRNA nanoparticles targeting
Bai X; Zhao G; Chen Q; Li Z; Gao M; Ho W; Xu X; Zhang XQ
Sci Adv; 2022 Jun; 8(25):eabn7162. PubMed ID: 35731866
[TBL] [Abstract][Full Text] [Related]
44. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
[TBL] [Abstract][Full Text] [Related]
45. A key role for NOX4 in epithelial cell death during development of lung fibrosis.
Carnesecchi S; Deffert C; Donati Y; Basset O; Hinz B; Preynat-Seauve O; Guichard C; Arbiser JL; Banfi B; Pache JC; Barazzone-Argiroffo C; Krause KH
Antioxid Redox Signal; 2011 Aug; 15(3):607-19. PubMed ID: 21391892
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway.
Dai WJ; Qiu J; Sun J; Ma CL; Huang N; Jiang Y; Zeng J; Ren BC; Li WC; Li YH
J Cell Physiol; 2019 Mar; 234(3):2552-2565. PubMed ID: 30144053
[TBL] [Abstract][Full Text] [Related]
47. Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx.
Vittal R; Walker NM; McLinden AP; Braeuer RR; Ke F; Fattahi F; Combs MP; Misumi K; Aoki Y; Wheeler DS; Wilke CA; Huang SK; Moore BB; Cao P; Lama VN
Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L39-L51. PubMed ID: 37933452
[TBL] [Abstract][Full Text] [Related]
48. The Antifibrotic Activity of Prostacyclin Receptor Agonism Is Mediated through Inhibition of YAP/TAZ.
Zmajkovicova K; Menyhart K; Bauer Y; Studer R; Renault B; Schnoebelen M; Bolinger M; Nayler O; Gatfield J
Am J Respir Cell Mol Biol; 2019 May; 60(5):578-591. PubMed ID: 30537446
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.
Lian N; Jin H; Zhu W; Zhang C; Qi Y; Jiang M; Mao J; Lu X; Zhao F; Xi B; Qi X; Li Y
Acta Histochem; 2022 Dec; 124(8):151961. PubMed ID: 36265204
[TBL] [Abstract][Full Text] [Related]
50. TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.
Hou J; Ma T; Cao H; Chen Y; Wang C; Chen X; Xiang Z; Han X
J Cell Physiol; 2018 Mar; 233(3):2409-2419. PubMed ID: 28731277
[TBL] [Abstract][Full Text] [Related]
51. A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Zhao T; Gong B; Luo S; Zhang R; Zhang L; Huang Y; Gao H; Gong T
Acta Biomater; 2023 Sep; 167():574-582. PubMed ID: 37356783
[TBL] [Abstract][Full Text] [Related]
52. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
53. Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis.
Li JM; Chang WH; Li L; Yang DC; Hsu SW; Kenyon NJ; Chen CH
Respir Res; 2023 May; 24(1):132. PubMed ID: 37194070
[TBL] [Abstract][Full Text] [Related]
54. m
Zhang JX; Huang PJ; Wang DP; Yang WY; Lu J; Zhu Y; Meng XX; Wu X; Lin QH; Lv H; Xie H; Wang RL
Mol Ther; 2021 Dec; 29(12):3436-3448. PubMed ID: 34111558
[TBL] [Abstract][Full Text] [Related]
55. Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
Kuse N; Kamio K; Azuma A; Matsuda K; Inomata M; Usuki J; Morinaga A; Tanaka T; Kashiwada T; Atsumi K; Hayashi H; Saito Y; Seike M; Gemma A
J Nippon Med Sch; 2020 Jul; 87(3):118-128. PubMed ID: 31776321
[TBL] [Abstract][Full Text] [Related]
56. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
Savary G; Dewaeles E; Diazzi S; Buscot M; Nottet N; Fassy J; Courcot E; Henaoui IS; Lemaire J; Martis N; Van der Hauwaert C; Pons N; Magnone V; Leroy S; Hofman V; Plantier L; Lebrigand K; Paquet A; Lino Cardenas CL; Vassaux G; Hofman P; Günther A; Crestani B; Wallaert B; Rezzonico R; Brousseau T; Glowacki F; Bellusci S; Perrais M; Broly F; Barbry P; Marquette CH; Cauffiez C; Mari B; Pottier N
Am J Respir Crit Care Med; 2019 Jul; 200(2):184-198. PubMed ID: 30964696
[No Abstract] [Full Text] [Related]
57. MiR-541-5p regulates lung fibrosis by targeting cyclic nucleotide phosphodiesterase 1A.
Ren L; Yang C; Dou Y; Zhan R; Sun Y; Yu Y
Exp Lung Res; 2017; 43(6-7):249-258. PubMed ID: 28816543
[TBL] [Abstract][Full Text] [Related]
58. The hedgehog and Wnt/β-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis.
Chen X; Shi C; Cao H; Chen L; Hou J; Xiang Z; Hu K; Han X
Cell Death Dis; 2018 May; 9(6):639. PubMed ID: 29844390
[TBL] [Abstract][Full Text] [Related]
59. MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway.
Ballester B; Milara J; Montero P; Cortijo J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204432
[TBL] [Abstract][Full Text] [Related]
60. Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.
Wang Y; Ding L; Li Z; Chen G; Sun M; Oupicky D
J Control Release; 2019 Nov; 314():12-24. PubMed ID: 31644934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
